证券日报网讯12月18日，晨曦航空（300581）在互动平台回答投资者提问时表示，公司截至2025年12月 10日股东户数约66000户。 ...

证券日报网讯 12月18日，晨曦航空在互动平台回答投资者提问时表示，公司的产品是可以用在商业航 天领域的，但是目前公司未开展该业务。 （文章来源：证券日报） ...

Group 1 - A total of 78 stocks in the A-share market experienced block trading today, with a total transaction value of 3.755 billion yuan [1] - The top three stocks by transaction value were Minsheng Bank (2.149 billion yuan), WuXi AppTec (430 million yuan), and Luxin Technology (119 million yuan) [1] - Among the stocks, 8 were traded at par, 3 at a premium, and 67 at a discount; the highest premium rates were for AVIC Optoelectronics (8.04%), Zhongke Shuguang (7.92%), and Haowei Group (2.07%) [1] Group 2 - The top buying amounts from institutional special seats were led by WuXi AppTec (251 million yuan) and Minsheng Bank (108 million yuan) [2] - The top selling amounts from institutional special seats included Jintian Titanium Industry (18.74 million yuan) and Huilong New Materials (9.97 million yuan) [2]

| 交易日期 | 证券代码 | 证券简称 | 成交价格 | 成交量 | 成交金额 | 买方营业部 | 卖方营业部 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | (元) | (万股/万份) | (万元) | | | | 2025-12-18 | 300581 | 晨曦航空 | 13.24 | 37.80 | 500.47 机构专用 | | 国信证券股份有限 | | | | | | | | | 公司陕西分公司 | | 2025-12-18 | 300581 | 晨曦航空 | 13.24 | 20.00 | 264.80 机构专用 | | 国信证券股份有限 | | | | | | | | | 公司陕西分公司 | 12月18日，晨曦航空大宗交易成交57.8万股，成交额765.27万元，占当日总成交额的2.78%，成交价 13.24元，较市场收盘价15.64元折价15.35%。 ...

格隆汇12月18日丨晨曦航空(300581.SZ)在投资者互动平台表示，公司的产品是可以用在商业航天领域 的，但是目前公司未开展该业务。 ...

证券日报网讯12月15日，晨曦航空（300581）在互动平台回答投资者提问时表示，截至2025年12月10日 公司股东户数约66000户。 ...

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has imposed corrective measures on Xi'an Morning Star Aviation Technology Co., Ltd. due to issues related to revenue recognition and failure to account for credit impairment losses on receivables, leading to inaccurate financial disclosures [1][2]. Group 1: Regulatory Actions - The Shaanxi Securities Regulatory Bureau has ordered Xi'an Morning Star Aviation to correct its financial reporting and issued warning letters to Chairman Wu Xingyu and CFO Liu Rong for their primary responsibility in the violations [2][3]. - The Shenzhen Stock Exchange's ChiNext Management Department has also issued a regulatory letter to the company and its executives, citing violations of the listing rules [2][3]. Group 2: Financial Reporting Issues - The company acknowledged that its revenue recognition for certain clients in Q3 2024 was incorrect, resulting in a reduction of reported revenue by 28.92 million yuan and affecting various financial metrics [4]. - The adjustments led to a significant decline in reported revenue and net profit for the first three quarters of 2024, with revenue revised down to 42.45 million yuan, a year-on-year decrease of 56.26% [5][6]. Group 3: Financial Performance - For 2024, the company reported a net loss attributable to shareholders of 31.66 million yuan, compared to a profit of 5.75 million yuan in 2023 [6]. - The company has experienced a decline in revenue over the years, with 2023 revenue at 233 million yuan and 2024 at 141 million yuan, indicating ongoing financial challenges [6].

西安晨曦航空科技股份有限公司 2024 年第三季度报告（更正后） 证券代码：300581 证券简称：晨曦航空 公告编号：2025-074 西安晨曦航空科技股份有限公司 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、完 整。 3.第三季度报告是否经过审计 □是 否 1 西安晨曦航空科技股份有限公司 2024 年第三季度报告（更正后） 一、主要财务数据 （一） 主要会计数据和财务指标 2024 年第三季度报告（更正后） 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 重要内容提示： 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年 | 年初至报告期末 | 年初至报告期末 | | --- | --- | --- | --- | --- | | | | 同期增减 | | 比上年同期增减 | | 营业收入（元） | 29,60 ...

证券代码：300581 证券简称：晨曦航空 公告编号：2025-073 现将相关事项公告如下： 一、概述 西安晨曦航空科技股份有限公司于 2025 年 12 月 12 日收到中国证券监督管 理委员会陕西监管局出具的《关于对西安晨曦航空科技股份有限公司采取责令改 正并对吴星宇、刘蓉采取出具警示函行政监管措施的决定》（陕证监措施字〔2025〕 47 号）（以下简称《决定书》），因公司 2024 年三季度对个别客户收入确认存在 跨期情形，导致公司 2024 年三季度相关数据披露不准确，不符合《企业会计准 则第 14 号——收入》第十三条的规定。根据《决定书》要求，现就公司于 2024 年 10 月 29 日在巨潮资讯网（http://www.cninfo.com.cn）披露的《西安晨曦航空 科技股份有限公司 2024 年第三季度报告》（公告编号：2024-082）中的部分内容 进行更正。具体如下： 二、本次更正对公司财务状况和经营成果的影响 西安晨曦航空科技股份有限公司 关于 2024 年第三季度报告更正的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 特别提 ...

Group 1 - Shouyao Holdings is planning to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries regarding the specifics of the listing [1] - Jiangsu Guoxin's subsidiary, Guoxin Mazhou, has completed the trial operation of a 1000MW coal-fired power unit, which is set to officially commence operations on December 12, 2025 [2] - Yuekang Pharmaceutical's mRNA tumor vaccine has received clinical trial approval from the National Medical Products Administration for treating advanced solid tumors [3] Group 2 - Dongli New Science plans to invest 666 million yuan in the restructuring of SAIC Hongyan, acquiring approximately 14.66% equity post-restructuring [4] - Longsheng Technology is set to invest approximately 350 million yuan in the establishment of an intelligent robot innovation center in Wuxi [5] - Shangwei Co. has received a government subsidy of 2.212 million yuan, which accounts for 13.53% of its audited net profit for 2024 [6] Group 3 - Anglikang has received drug registration certificates for Diclofenac Sodium Enteric-Coated Tablets and approval for a supplemental application for Sacubitril/Valsartan Sodium Tablets [7] - Guangzhou Development has received acceptance notices for the registration of 8 billion yuan in medium-term notes and 6 billion yuan in short-term financing bonds [8] - Kebo Da plans to increase capital by 21.2 million euros (approximately 174 million yuan) in its wholly-owned subsidiary in Germany [9][10] Group 4 - Changguang Huaxin has received a total of 11.6672 million yuan in government subsidies, including 8.0552 million yuan related to income [11] - Haizheng Pharmaceutical's subsidiary has received a European Pharmacopoeia suitability certificate for its raw material [12] - Qianjin Pharmaceutical's subsidiary has received a drug registration certificate for Lurasidone Hydrochloride Tablets, used for treating schizophrenia [13] Group 5 - Daimai Co. has received a warning letter from the Shanghai Securities Regulatory Bureau due to failure to timely disclose a significant event related to a fire incident [14] - ST Changyao's subsidiary has recently ceased production due to financial difficulties and competitive pressures in the photovoltaic industry [15] - Guodian Power is investing in the construction of a 2×1000MW expansion project at the Ganbi Power Plant, with a total dynamic investment of 7.218 billion yuan [16] Group 6 - Kaichuang International's subsidiary has completed the handover of a tuna purse seine vessel, expected to be operational by 2026 [16] - Tieke Rail plans to sign an energy management agreement for a distributed photovoltaic project, which is expected to save approximately 1.441 million yuan in electricity costs over 25 years [18] - Bailian Co. plans to sign a land compensation agreement with Friendship Logistics, with a total compensation of 103 million yuan [19] Group 7 - Dayu Water-saving's subsidiary has been pre-awarded two high-standard farmland construction projects, with total expected amounts of 137 million yuan and 135 million yuan respectively [20] - Tianma Technology reported a total eel output of approximately 1197.15 tons in November, with sales prices ranging from 53,000 yuan/ton to 89,000 yuan/ton [21] - Guorui Technology's subsidiary has been shortlisted for the GXLF project with a bid of 76 million yuan [22] Group 8 - Qingdao Food's deputy general manager has resigned for personal reasons [23] - Guosheng Zhike plans to use up to 900 million yuan of idle funds for cash management [24] - Guodian Nanrui plans to use up to 23 billion yuan of idle funds for entrusted wealth management [25] Group 9 - Jiahuan Energy plans to merge its wholly-owned subsidiary, Zhejiang Jiahuan Hydrogen Peroxide Co., Ltd., through an overall absorption merger [26] - Ganyue Expressway reported vehicle toll service revenue of 309 million yuan for November [27] - Jinling Hotel's chairman has resigned due to work changes [28] Group 10 - Lisheng Pharmaceutical's subsidiary has received drug registration certificates for Apremilast Tablets [29] - Baotai has received a positive opinion from the European Medicines Agency for Gotenfia® for various inflammatory conditions [30] - ST Zhisheng has been awarded a smart city governance project with a bid amount of 104 million yuan [31] Group 11 - Chenxi Aviation and its related personnel have received administrative regulatory measures from the Shaanxi Securities Regulatory Bureau due to financial reporting issues [32] - Portong Medical has appointed Xia Canglan as the new deputy general manager [33] - Maide Medical plans to repurchase shares with a total amount between 20 million and 40 million yuan [34] Group 12 - Jimin Health plans to establish a joint venture with a total investment of 600 million yuan, focusing on AI and software development [35] - Beilu Pharmaceutical has received a drug registration certificate for Pioglitazone Metformin Tablets [36] - Hainan Mining plans to entrust the overall management of the Shiluo Iron Mine to a construction company for three years, with a total contract amount of approximately 818 million yuan [38] Group 13 - Huiyu Pharmaceutical has received a drug registration certificate for Nicardipine Hydrochloride Injection [39] - Baoland has received a government subsidy of 10 million yuan related to income [40] - Qingdao Port has terminated the acquisition of 100% equity in an oil company and 50% equity in Rizhao Shihua due to regulatory concerns [41]